IM Cannabis (IMCC) Non-Current Deferred Tax Liability (2019 - 2026)
IM Cannabis' (IMCC) quarterly Non-Current Deferred Tax Liability came in at $213657.3 in Q1 2026, down 32.32% year-on-year from $315703.2 in Q1 2025, and down 16.07% quarter-over-quarter from $254565.6 in Q4 2025.
IM Cannabis (IMCC) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends
IM Cannabis' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $213657.3 for Q1 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 32.32% year-over-year to $213657.3 in Q1 2026; TTM through Mar 2026 was $213657.3, a 32.32% decrease from a year earlier, with the FY2025 full-year figure at $254565.6, down 28.43% from the prior year.
- Non-Current Deferred Tax Liability retreated to $213657.3 in Q1 2026 per IMCC's latest filing, from $254565.6 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $5.0 million in Q1 2022 and bottomed at $213657.3 in Q1 2026.
- The 5-year median for Non-Current Deferred Tax Liability is $669386.1 (2024), against an average of $1.0 million.
- Across the five-year window, Non-Current Deferred Tax Liability plunged 81.41% in 2023 and dropped 19.31% in 2025, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $981288.3 in 2022, then fell by 27.92% to $707357.7 in 2023, then slumped by 50.72% to $348618.5 in 2024, then declined by 26.98% to $254565.6 in 2025, then declined by 16.07% to $213657.3 in 2026.
- Per Business Quant, the three latest IMCC Non-Current Deferred Tax Liability figures stand at $213657.3 (Q1 2026), $254565.6 (Q4 2025), and $290654.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213,657.27 |
| Mar 31, 2026 | 213,657.27 |
| Dec 31, 2025 | 254,565.63 |
| Dec 31, 2025 | 254,565.63 |
| Sep 30, 2025 | 290,654.00 |
| Sep 30, 2025 | 290,654.00 |
| Jun 30, 2025 | 310,336.37 |
| Jun 30, 2025 | 310,336.37 |
| Mar 31, 2025 | 315,703.16 |
| Mar 31, 2025 | 315,703.16 |
| Dec 31, 2024 | 348,618.53 |
| Dec 31, 2024 | 348,618.53 |
| Sep 30, 2024 | 367,992.81 |
| Sep 30, 2024 | 367,992.81 |
| Jun 30, 2024 | 384,579.93 |
| Jun 30, 2024 | 384,579.93 |
| Mar 31, 2024 | 669,386.11 |
| Mar 31, 2024 | 669,386.11 |
| Dec 31, 2023 | 707,357.71 |
| Dec 31, 2023 | 707,357.71 |